Angiotensin-Converting Enzyme 2 as a Versatile Player in the Management of Coronavirus Disease 2019

Link to article at PubMed

Amano T. J Diabetes Investig 2020.


In view of the global coronavirus disease 2019 (COVID-19) pandemic, there are ongoing efforts aimed at predicting potential factors causing clinical exacerbation of COVID-19 and at seeking effective therapies for COVID-19.Recent studies have indicated that severe acute respiratory coronavirus 2 (SARS-CoV-2) uses angiotensin-converting enzyme 2 (ACE2) as a receptor for cellular invasion and subsequent replication.

PMID:32657484 | DOI:10.1111/jdi.13346

Leave a Reply

Your email address will not be published.